Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John K. Clarke currently holds 24,000 shares of aTYR PHARMA INC (LIFE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John K. Clarke has been a net seller of LIFE stock. They have purchased $3.4M and sold $8.4M worth of shares.
John K. Clarke's most recent insider trade was on May 22, 2024, when they sold 24,000 shares at $0.00 per share.
John K. Clarke serves as Executive at aTYR PHARMA INC (LIFE). They have executed 80 insider transactions totaling $11.8M over their tenure at the company.
John K. Clarke holds the position of Executive at aTYR PHARMA INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
John K. Clarke has shown a selling trading pattern, with $3.4M in total purchases and $8.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John K. Clarke was on Feb 20, 2008, when they sold $40.2M worth of EICU shares. This transaction involved 3,347,923 shares at $12.00 per share.
John K. Clarke currently owns 24,000 shares of aTYR PHARMA INC (LIFE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John K. Clarke's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John K. Clarke has 80 Form 4 filings on record as an insider at aTYR PHARMA INC.
Set alerts for John K. Clarke and 40,000+ other insiders.